Cargando…

Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity

BACKGROUND: Th2 cells play an important role in intermittent allergic rhinitis (IAR). Interleukin (IL)-33 stimulates the production of Th2-associated cytokines. IL-33 binds to ST2 receptor which is highly expressed on mast cells and selectively on Th2 cells. IL-33 and ST2 might be involved in the Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Glück, Joanna, Rymarczyk, Barbara, Rogala, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Birkhäuser Verlag Basel 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345109/
https://www.ncbi.nlm.nih.gov/pubmed/22349136
http://dx.doi.org/10.1007/s00011-012-0443-9
_version_ 1782232108914180096
author Glück, Joanna
Rymarczyk, Barbara
Rogala, Barbara
author_facet Glück, Joanna
Rymarczyk, Barbara
Rogala, Barbara
author_sort Glück, Joanna
collection PubMed
description BACKGROUND: Th2 cells play an important role in intermittent allergic rhinitis (IAR). Interleukin (IL)-33 stimulates the production of Th2-associated cytokines. IL-33 binds to ST2 receptor which is highly expressed on mast cells and selectively on Th2 cells. IL-33 and ST2 might be involved in the Th2-mediated immune response. OBJECTIVE: We analyzed the serum level of IL-33 and its receptor ST2 in patients with IAR sensitive to grass and/or tree pollen to assess if the serum level of IL-33 and/or ST2 may be a marker of the disease severity. METHODS: IL-33, ST2 and total immunoglobulin (Ig) E were measured in sera of patients with IAR sensitive to birch and/or grass pollen and in patients with controlled bronchial asthma and in non-allergic controls. IAR severity was assessed by total nasal symptom score. RESULTS: Serum levels of IL-33 in patients with IAR were comparable with patients with bronchial asthma and were significantly higher in patients with IAR (P = 0.0035) and in patients with bronchial asthma (P = 0.008) than in controls. Serum levels of IL-33 correlated with disease severity. CONCLUSION: Elevated level of IL-33 in sera of patients with IAR sensitive to tree and/or grass pollen and the correlation of IL-33 with the disease severity suggest that IL-33 is involved in the pathogenesis of intermittent allergic rhinitis.
format Online
Article
Text
id pubmed-3345109
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher SP Birkhäuser Verlag Basel
record_format MEDLINE/PubMed
spelling pubmed-33451092012-05-24 Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity Glück, Joanna Rymarczyk, Barbara Rogala, Barbara Inflamm Res Original Research Paper BACKGROUND: Th2 cells play an important role in intermittent allergic rhinitis (IAR). Interleukin (IL)-33 stimulates the production of Th2-associated cytokines. IL-33 binds to ST2 receptor which is highly expressed on mast cells and selectively on Th2 cells. IL-33 and ST2 might be involved in the Th2-mediated immune response. OBJECTIVE: We analyzed the serum level of IL-33 and its receptor ST2 in patients with IAR sensitive to grass and/or tree pollen to assess if the serum level of IL-33 and/or ST2 may be a marker of the disease severity. METHODS: IL-33, ST2 and total immunoglobulin (Ig) E were measured in sera of patients with IAR sensitive to birch and/or grass pollen and in patients with controlled bronchial asthma and in non-allergic controls. IAR severity was assessed by total nasal symptom score. RESULTS: Serum levels of IL-33 in patients with IAR were comparable with patients with bronchial asthma and were significantly higher in patients with IAR (P = 0.0035) and in patients with bronchial asthma (P = 0.008) than in controls. Serum levels of IL-33 correlated with disease severity. CONCLUSION: Elevated level of IL-33 in sera of patients with IAR sensitive to tree and/or grass pollen and the correlation of IL-33 with the disease severity suggest that IL-33 is involved in the pathogenesis of intermittent allergic rhinitis. SP Birkhäuser Verlag Basel 2012-02-15 2012 /pmc/articles/PMC3345109/ /pubmed/22349136 http://dx.doi.org/10.1007/s00011-012-0443-9 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Research Paper
Glück, Joanna
Rymarczyk, Barbara
Rogala, Barbara
Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title_full Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title_fullStr Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title_full_unstemmed Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title_short Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
title_sort serum il-33 but not st2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
topic Original Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345109/
https://www.ncbi.nlm.nih.gov/pubmed/22349136
http://dx.doi.org/10.1007/s00011-012-0443-9
work_keys_str_mv AT gluckjoanna serumil33butnotst2leveliselevatedinintermittentallergicrhinitisandisamarkerofthediseaseseverity
AT rymarczykbarbara serumil33butnotst2leveliselevatedinintermittentallergicrhinitisandisamarkerofthediseaseseverity
AT rogalabarbara serumil33butnotst2leveliselevatedinintermittentallergicrhinitisandisamarkerofthediseaseseverity